IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Corrigendum]
2015 ◽
Vol 39
◽
pp. S92-S97
◽
2015 ◽
Vol 10
(2)
◽
pp. 455
◽
2018 ◽
Vol 37
(1)
◽
Keyword(s):
2020 ◽
Vol 21
(15)
◽
pp. 5276
◽